Status:
TERMINATED
Effect of Probiotic Supplement on Bowel Function
Lead Sponsor:
Danisco
Conditions:
Irritable Bowel Syndrome
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to analyse the effect of probiotic supplement on symptoms of irritable bowel syndrome.
Detailed Description
The aim of the intervention is to analyse the effect of a probiotic supplement in a dose-responsive set up on symptoms of irritable bowel syndrome (IBS). Fulfillment of Rome III criteria will be used ...
Eligibility Criteria
Inclusion
- Subjects aged 18 to 65 with functional bowel symptoms and fulfilling Rome III criteria for IBS will be recruited. Sufficient general health and orientation for participating in the study is required and will be evaluated by the MDs.
Exclusion
- Diagnosed or suspected organic gastrointestinal diseases or severely impaired general health are exclusion criteria.
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
149 Patients enrolled
Trial Details
Trial ID
NCT01475929
Start Date
June 1 2011
End Date
May 1 2012
Last Update
August 13 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herttoniemi Hospital
Helsinki, Helsinki, Finland, 00800